Microbix Biosystems Hosts Ontario Premier Doug Ford
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF) proudly welcomed Premier Doug Ford and MPP Deepak Anand during an insightful visit to its facilities in Ontario. The meeting provided a platform to discuss the company’s cutting-edge diagnostic technologies and the potential for improving health outcomes while driving down healthcare costs.
Celebrating Ontario's Life Sciences Innovations
During his remarks, Microbix CEO, Cameron Groome, expressed gratitude for the attention from provincial leaders. "We are honored to be recognized by Premier Ford and MPP Anand as a standout in Ontario's life sciences landscape. Our innovative products, developed and manufactured right here, play a critical role in the accurate diagnosis of diseases globally," Groome stated. This acknowledgment highlights the essential role companies like Microbix play in enhancing local economies and the healthcare sector.
Support from the Provincial Government
Microbix's COO, Dr. Ken Hughes, emphasized how the support from the Ontario government has been instrumental in the company’s journey. With over C$ 2 million in grant funding from the Ontario Together Funds, Microbix has been able to secure a foothold in the rapidly evolving healthcare market. These initiatives have allowed for the development of products that lead the charge in healthcare innovations.
Microbix's Innovative Product Line
The company specializes in visualizing and producing critical biological products crucial for human health. With more than 120 skilled professionals, Microbix is on track to achieve monthly sales exceeding C$ 2 million. The range of products includes high-quality antigens for immunoassays and laboratory quality assessment products (QAPs™), which are vital for ensuring clinical lab proficiency testing.
Global Reach and Trust in Microbix
Microbix's products are now utilized across over 30 countries, supported by an extensive network of distributors. Their commitment to quality assurance is reflected in their ISO 9001 and ISO 13485 accreditations, as well as certifications from the U.S. FDA and Health Canada. The company is dedicated to adhering to global standards, ensuring their products are recognized worldwide for their efficacy and reliability.
Future of Microbix and the Healthcare Sector
The emphasis on innovation underscores Microbix’s reputation in developing proprietary products, including Kinlytic® urokinase, a drug essential for treating blood clots. The integration of advanced reagents for molecular diagnostic testing furthermore solidifies Microbix’s standing as a leader in the life sciences field.
Contact Information
For those seeking more information about Microbix, the company encourages inquiries through its dedicated contact resources:
Cameron Groome, CEO
(905) 361-8910
Jim Currie, CFO
(905) 361-8910
Deborah Honig, Investor Relations
Adelaide Capital Markets
(647) 203-8793
Frequently Asked Questions
What is Microbix Biosystems Inc.?
Microbix Biosystems Inc. is an Ontario-based life sciences company specializing in diagnostic technologies and biological products.
What products does Microbix offer?
Microbix offers a range of products, including antigens for immunoassays and laboratory quality assessment products that support clinical laboratories.
Who attended the recent visit at Microbix?
Ontario Premier Doug Ford and local MPP Deepak Anand visited the Microbix facilities to learn about their innovations and contributions to healthcare.
How has the Ontario government supported Microbix?
The Ontario government has provided over C$ 2 million in grant funding through its Ontario Together Funds, fostering Microbix's growth and innovation.
Where can I find more information about Microbix?
For additional information about Microbix and its products, you can visit their corporate website or contact them through their listed channels.
